As of 2026-10-01, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.11) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -324.1%.
The range of the Relative Valuation is (0.91) - (1.29) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.5x | 8.8x |
| Forward P/E multiples | 7.4x - 11.2x | 9.3x |
| Fair Price | (0.91) - (1.29) | (1.11) |
| Upside | -284.7% - -360.7% | -324.1% |
| Date | P/E |